
Many hurdles lie between a biosimilar and success on the market. In particular, there are three main questions that companies will be asking themselves.
Paul Greenland is Biosimilars Marketing Director for Europe, Middle East and Africa at Hospira.

Published: September 1st 2010 | Updated: